Services

Quick Fact

 

Our pharmacists designed and implemented a formulary for the Massachusetts Medicaid program, MassHealth. As a result, the MassHealth Drug List has helped the state become a national leader in generic use. About 80 percent of the prescriptions written for MassHealth members are generic. 

Pipeline Trends

 

Pipeline Trends

PIPELINE TRxENDS is produced by Commonwealth Medicine’s Clinical Pharmacy Services division and distributed to our clients twice yearly.

Pharmacy

Our Clinical Pharmacy Services team offers flexible, evidence-based pharmacy management solutions and resources to help our clients build fiscally efficient pharmacy programs.

With a consulting team that includes more than 60 clinical pharmacists — half of whom have doctoral pharmacy degrees — we deliver cost-containment and disease-management strategies that support positive clinical outcomes.

  • Data analytics
    Our pharmacists analyze medical and pharmacy claims data. Then we develop recommendations designed to advance health care outcomes and contain or reduce costs.
  • Drug utilization review
    We develop prospective and retrospective drug utilization review programs. We also consult on and support drug utilization review boards as well as pharmacy and therapeutics committees.
  • Formulary management
    We base our formulary management recommendations on in-depth safety, efficacy, and cost analyses conducted by our pharmacists.
  • Medication therapy management
    Our programs ensure that patients are receiving medications that most fully control their diseases or conditions — and that they’re using them correctly.
  • New drug review
    Our in-depth, up-to-date reviews detail both clinical and fiscal implications of new drugs — within 10 days of their market availability.
  • Pharmacoeconomic modeling
    Using evidence-based modeling, we determine whether products and treatments are clinically and economically sound.
  • Prescriber education
    After reviewing client data, our prescriber education team collaborates with providers to improve their adherence to formularies and preferred drug lists.